Reuter VE - Search Results

1

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.

Teo MY, Guercio BJ, Arora A, Hao X, Regazzi AM, Donahue T, Herr HW, Goh AC, Cha EK, Pietzak E, Donat SM, Dalbagni G, Bochner BH, Olgac S, Sarungbam J, Sirintrapun SJ, Chen YB, Gopalan A, Fine SW, Tickoo SK, Reuter VE, Weigelt B, Schultheis AM, Funt SA, Bajorin DF, Solit DB, Iyer G, Ostrovnaya I, Rosenberg JE, Al-Ahmadie H. Teo MY, et al. Among authors: reuter ve. Clin Genitourin Cancer. 2022 Oct;20(5):431-441. doi: 10.1016/j.clgc.2022.05.005. Epub 2022 May 11. Clin Genitourin Cancer. 2022. PMID: 35676169 Free PMC article.

2

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.

Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ. Wood DP Jr, et al. Cancer. 1992 Nov 1;70(9):2354-7. doi: 10.1002/1097-0142(19921101)70:9<2354::aid-cncr2820700924>3.0.co;2-u. Cancer. 1992. PMID: 1382832

3

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

4

Cell surface differentiation antigens of normal urothelium and bladder tumors.

Dalbagni G, Reuter VE, Sheinfeld J, Fradet Y, Fair WR, Cordon-Cardo C. Dalbagni G, et al. Among authors: reuter ve. Semin Surg Oncol. 1992 Sep-Oct;8(5):293-9. doi: 10.1002/ssu.2980080508. Semin Surg Oncol. 1992. PMID: 1462100 Review.

5

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.

Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Cordon-Cardo C, et al. Among authors: reuter ve. J Natl Cancer Inst. 1992 Aug 19;84(16):1251-6. doi: 10.1093/jnci/84.16.1251. J Natl Cancer Inst. 1992. PMID: 1640484

6

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: reuter ve. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

7

Perirenal lipoma versus renal cell carcinoma.

Mydlo JH, Shore N, Reuter V, Herr HW. Mydlo JH, et al. Urology. 1991 Jul;38(1):67-9. doi: 10.1016/0090-4295(91)80019-4. Urology. 1991. PMID: 1866864

8

M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Darshaw D, Reuter V, et al. Scher H, et al. Prog Clin Biol Res. 1990;353:179-86. Prog Clin Biol Res. 1990. PMID: 2217417 No abstract available.

9

Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.

Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T, et al. Fair WR, et al. Semin Urol. 1990 Aug;8(3):190-6. Semin Urol. 1990. PMID: 2399387 No abstract available.

10

Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.

Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr HW, Whitmore WF, Cordon-Cardo C. Sheinfeld J, et al. Among authors: reuter ve. J Urol. 1990 Feb;143(2):285-8. doi: 10.1016/s0022-5347(17)39935-4. J Urol. 1990. PMID: 2405185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page